Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Bilogical Research Centre, Szeged | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Prospective assay for SARS-CoV-2 antibody detection indirectly by immunofluorescence: SARS-CoV2 IIF method
Sample preparation, serum separation by centrifugation
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Positive group | Subjects are diagnosed with SARS-CoV2 by qPCR assay. |
| |
| Negative group | Subject were 2 times proved negative SARS-CoV2 by qPCR assay. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Immunfluorescence | Diagnostic Test | Serum indirect immunofluorescent (IIF) method is used, analysis is performed under an automated microscope. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Sensitivity of the method by SARS-CoV2 ELISA compared | Sensitivity of the method by SARS-CoV2 ELISA compared | 8 months |
| Measure | Description | Time Frame |
|---|---|---|
| Detectability of the antibodies IgA type against SARS-CoV2 virus | Detectability of the antibodies IgA type against SARS-CoV2 virus in the early stages of the disease. | 8 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Adults, Hungarian
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Katalin Burián, MD | Contact | +36 62 544 000 | burian.katalin@med.u-szeged.hu | |
| Dávid Pintér, Pharm. D. | Contact |
| Name | Affiliation | Role |
|---|---|---|
| Katalin Burián, MD | University of Szeged, Institute of Clinical Microbilogy | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Szeged, Albert Szent-Györgyi Health Center | Recruiting | Szeged | Hungary |
Not provided
| Label | URL |
|---|---|
| COVID-19 situation update worldwide | View source |
| COVID-19 CORONAVIRUS PANDEMIC | View source |
| A serological assay to detect SARS-CoV-2 seroconversion in humans |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| View source |
| Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020 | View source |